Pathology

USA Health Launches In-House Molecular Cancer Tests For Precision Medicine

USA Health now offers two in-house molecular oncology tests—BRAF Gene Mutation Assay and Microsatellite Instability (MSI) Assay—for cancer patients. Onsite testing means patients receive results...

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.